Latest Filgrastim Stories
THOUSAND OAKS, Calif., May 13, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data at the 51(st) Annual Meeting of the American Society of Clinical Oncology (ASCO) will showcase the
Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy THOUSAND OAKS, Calif., March
Company currently has two biosimilar applications (filgrastim [Neupogen(®)]) and pegfilgrastim [Neulasta(®)]) under active review by FDA. TORONTO, Feb.
Surveyed European Oncologists Expect to Use Future Biosimilar G-CSFs in a Greater Proportion of Eligible Patients than Biosimilar MAbs, According to Findings from Decision Resources Group BURLINGTON,
RnRMarketResearch.com adds "Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2014" to its store.
- A woman chauffeur.
- A woman who operates an automobile.